DENVER, NC / August 23, 2019 / CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) (“CVR Medical”) a Canadian listed and US based healthcare company in the medical device sector announces that Chief Financial Officer (CFO) Mr. Tommy Harris has resigned from his role, effective August 20, 2019. Current Director, Dr. Dallas Hack, will act as interim CFO while an appropriate replacement is found.
Colonel Hack has had a decorated medical and military career. Prior to his military career, Colonel Hack developed expertise in computer sciences and engineering, and served as Vice President for several biomedical companies. Dr. Hack directed the Combat Casualty Care Research Program (CCCRP) at the US Army Medical Research & Materiel Command (USAMRMC) from 2008 to 2014 where he led and coordinated over $2 billion in Trauma Research and Development funding (including traumatic brain injury) across all Department of Defense groups. The initiatives Dr. Hack developed have dramatically improved trauma care worldwide and have fundamentally changed the way the Food and Drug Administration regulates brain injury product development. Colonel Hack’s other appointments include (among others) Command Surgeon for the Multinational Force in Iraq, Faculty Instructor at the US Army War College in Carlisle, PA, and Commander of the SHAPE Healthcare Facility in Mons, Belgium. Colonel Hack is a recipient the Bronze Star and the Legion of Merit (twice) and was recognized as the 2015 Alumnus of the Year by his medical school, Loma Linda University.
About CVR Medical
CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary Carotid Stenotic Scan (CSS). The CSS device is a diagnostic tool that encompasses subsonic, infrasonic, and low frequency sound wave analysis technology. The CSS is a patented device designed to detect and measure carotid arterial stenosis. CVR is currently in pivotal clinical trials in preparation for its planned submission to the FDA. CVR is led by an experienced and proven team of professionals with extensive healthcare, medical device, international expansion, regulatory and sales experience. CVR Medical trades on the TSX Venture Exchange under the symbol CVM. Additional information regarding the Company can be found in our recent filings with the SEDAR as well as the information maintained on our website at www.cvrmed.com
ON BEHALF OF THE BOARD:
(signed) “Peter Bakema”
CEO, President & Director